The ONE Stock to Buy in April

The Rock Solid $3.2 Billion Blue Chip Hospitals Love But Investors Undervalue Fellow Investor, The stock market just goofed and that's good news for us. Investors got it all wrong when this medical technology blue chip reported results in February. A selloff ensued that Taesik Yoon, editor of our flagship advisory, Forbes Investor, says "…lacks any real merit." So what's the good news? Wall Street has just set the stage for us to profit fast on this company's… Strong Rebound! The company is beginning to reap the rewards of its recent acquisition of a competitor. Revenue has jumped 42.2%. Profit margins are widening. And as you'll discover in your free copy of The One Stock to Buy in April… Capital orders surged 25% year–over–year New product launches for the company's ICU franchise and clinical workflow solutions are poised for especially "strong growth for the rest of the year" The new FDA clearance of robotic–assisted surgical tables is yet another growth engine. The company has a first–of–its–kind robotic–assisted surgical system that allows surgical teams to make table adjustments in real time, during surgical procedures Hospitals depend on this blue chip for an extensive range of supplies and innovative patient care systems including medical–surgical and intensive care unit beds,operating room equipment, lifts and other devices for the safe movement of patients,ventilators, defibrillators and much, much more. Click here to get the full profile of The One Stock To Buy In April. DOWNLOAD MY FREE REPORT Sincerely, Charles Morgan, Associate Publisher Forbes Investing Newsletters P.S. You might think you know this company. After all, it's a $3.2 billion blue chip that pays a dividend. But chances are, you've never heard of it. See for yourself. .You may also send your opt-out request in the mail directly to Forbes Media LLC, Attn: Privacy Administrator 499 Washington Blvd Jersey City, NJ 07310